Please assess the completion status of the following clinical trial:

Trial Title: Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Advanced heart failure~* WET ≥ 12~* Systolic blood pressure ≤ 110 mmHg~* Serum sodium ≤ 135 mEq/L~* Left systolic ventricular insufficiency (FE \< 35%) note for at least 6 months~* Class NYHA III-IV despite medical treatment maximal~Exclusion Criteria:~* Acute coronary syndrome~* Shock cardiogenic~* Chronic renal failure stage V

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Continuous infusion of loop diuretics (Type: ACTIVE_COMPARATOR): Furosemide continuous infusion: 125 or 250 mg die
- Intermittent infusion of loop diuretics (Type: ACTIVE_COMPARATOR): Furosemide bolus intermittent: 125 or 250 mg die

Based on this trial design, predict the completion outcome and termination type (if applicable).